Siga Technologies INC Property, Plant and Equipment, Gross
Siga Technologies INC (SIGA) had Property, Plant and Equipment, Gross of $8.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $8.28M.
- 2026-03-31: Property, Plant and Equipment, Gross $8.27M.
- 2025-12-31: Property, Plant and Equipment, Gross $7.64M.
- 2025-09-30: Property, Plant and Equipment, Gross $7.61M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $8.28M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.27M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $7.64M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $7.61M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $7.36M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $7.37M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.36M 10-K · filed 2026-03-10 |
| 2024-09-30 | $7.34M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $7.38M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $6.91M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $6.91M 10-K · filed 2025-03-11 |
| 2023-09-30 | $6.92M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.92M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.89M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.89M 10-K · filed 2024-03-12 |
| 2022-09-30 | $6.92M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.95M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.95M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.99M 10-K · filed 2023-03-02 |
| 2021-09-30 | $6.96M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.96M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.22M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.27M 10-K · filed 2022-03-03 |
| 2020-09-30 | $6.36M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.36M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $6.36M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.34M 10-K · filed 2021-03-04 |
| 2019-09-30 | $6.34M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $6.32M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $6.32M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $3.42M 10-K · filed 2020-03-05 |
| 2018-09-30 | $3.34M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $3.50M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $3.49M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $3.49M 10-K · filed 2019-03-06 |
| 2017-09-30 | $3.44M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.77M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $3.76M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.77M 10-K · filed 2018-03-06 |
| 2016-09-30 | $3.76M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $3.76M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $3.76M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $3.75M 10-K · filed 2017-03-07 |
| 2015-09-30 | $3.72M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $3.66M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $4.33M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $4.33M 10-K · filed 2016-03-04 |
| 2014-09-30 | $4.33M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $4.33M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $4.32M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $6.78M 10-K · filed 2015-03-06 |
| 2013-09-30 | $6.49M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $6.28M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $6.19M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $5.93M 10-K · filed 2014-03-10 |
| 2011-12-31 | $6.47M 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |